CRDL
Price
$2.00
Change
+$0.02 (+1.01%)
Updated
Sep 11 closing price
Capitalization
232.7M
61 days until earnings call
Intraday BUY SELL Signals
SNOA
Price
$1.30
Change
-$0.01 (-0.76%)
Updated
Sep 11 closing price
Capitalization
6.22M
65 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

CRDL vs SNOA

CRDL vs SNOA Comparison Chart in %
loading
loading
View a ticker or compare two or three
VS
CRDL vs. SNOA commentary
Sep 12, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CRDL is a Hold and SNOA is a Hold.

Interact to see
Advertisement
SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
CRDL($233M) has a higher market cap than SNOA($6.23M). CRDL YTD gains are higher at: 109.163 vs. SNOA (-64.148). SNOA has higher annual earnings (EBITDA): -1.27M vs. CRDL (-35.77M). CRDL has more cash in the bank: 26.1M vs. SNOA (5.34M). CRDL has less debt than SNOA: CRDL (107K) vs SNOA (739K). SNOA has higher revenues than CRDL: SNOA (21.9M) vs CRDL (0).
CRDLSNOACRDL / SNOA
Capitalization233M6.23M3,743%
EBITDA-35.77M-1.27M2,814%
Gain YTD109.163-64.148-170%
P/E RatioN/AN/A-
Revenue021.9M-
Total Cash26.1M5.34M489%
Total Debt107K739K14%
FUNDAMENTALS RATINGS
CRDL vs SNOA: Fundamental Ratings
CRDL
SNOA
OUTLOOK RATING
1..100
4325
VALUATION
overvalued / fair valued / undervalued
1..100
86
Overvalued
54
Fair valued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
10097
PRICE GROWTH RATING
1..100
3464
P/E GROWTH RATING
1..100
10047
SEASONALITY SCORE
1..100
85n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

SNOA's Valuation (54) in the Pharmaceuticals Other industry is in the same range as CRDL (86) in the null industry. This means that SNOA’s stock grew similarly to CRDL’s over the last 12 months.

SNOA's Profit vs Risk Rating (100) in the Pharmaceuticals Other industry is in the same range as CRDL (100) in the null industry. This means that SNOA’s stock grew similarly to CRDL’s over the last 12 months.

SNOA's SMR Rating (97) in the Pharmaceuticals Other industry is in the same range as CRDL (100) in the null industry. This means that SNOA’s stock grew similarly to CRDL’s over the last 12 months.

CRDL's Price Growth Rating (34) in the null industry is in the same range as SNOA (64) in the Pharmaceuticals Other industry. This means that CRDL’s stock grew similarly to SNOA’s over the last 12 months.

SNOA's P/E Growth Rating (47) in the Pharmaceuticals Other industry is somewhat better than the same rating for CRDL (100) in the null industry. This means that SNOA’s stock grew somewhat faster than CRDL’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
CRDLSNOA
RSI
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 3 days ago
89%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
86%
Momentum
ODDS (%)
Bearish Trend 2 days ago
86%
Bearish Trend 2 days ago
90%
MACD
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
90%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
88%
Bearish Trend 2 days ago
89%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
83%
Bearish Trend 2 days ago
90%
Advances
ODDS (%)
Bullish Trend 4 days ago
80%
Bullish Trend 5 days ago
81%
Declines
ODDS (%)
Bearish Trend 16 days ago
87%
Bearish Trend 13 days ago
90%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 5 days ago
90%
Aroon
ODDS (%)
Bullish Trend 2 days ago
85%
Bearish Trend 5 days ago
90%
COMPARISON
Comparison
Sep 12, 2026
Stock price -- (CRDL: $2.00 vs. SNOA: $1.30)
Brand notoriety: CRDL and SNOA are both not notable
Both companies represent the Pharmaceuticals: Generic industry
Current volume relative to the 65-day Moving Average: CRDL: 100% vs. SNOA: 19%
Market capitalization -- CRDL: $232.7M vs. SNOA: $6.22M
CRDL [@Pharmaceuticals: Generic] is valued at $232.7M. SNOA’s [@Pharmaceuticals: Generic] market capitalization is $6.22M. The market cap for tickers in the [@Pharmaceuticals: Generic] industry ranges from $2.12K to $63.66B. The average market capitalization across the [@Pharmaceuticals: Generic] industry is $4B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is overvalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CRDL’s FA Score shows that 0 FA rating(s) are green while SNOA’s FA Score has 0 green FA rating(s).

  • CRDL’s FA Score: 0 green, 5 red.
  • SNOA’s FA Score: 0 green, 5 red.
According to our system of comparison, SNOA is a better buy in the long-term than CRDL.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CRDL’s TA Score shows that 2 TA indicator(s) are bullish while SNOA’s TA Score has 4 bullish TA indicator(s).

  • CRDL’s TA Score: 2 bullish, 6 bearish.
  • SNOA’s TA Score: 4 bullish, 6 bearish.
According to our system of comparison, SNOA is a better buy in the short-term than CRDL.

Price Growth

CRDL (@Pharmaceuticals: Generic) experienced а -9.32% price change this week, while SNOA (@Pharmaceuticals: Generic) price change was -1.51% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Generic industry was -5.31%. For the same industry, the average monthly price growth was -4.84%, and the average quarterly price growth was +30.17%.

Reported Earning Dates

CRDL is expected to report earnings on Nov 12, 2026.

SNOA is expected to report earnings on Nov 16, 2026.

Industries' Descriptions

@Pharmaceuticals: Generic (-5.31% weekly)

A generic drug contains the same chemical substance as a drug that was originally protected by patents. Generic drugs are generally sold at cheaper price points, compared to name-brand pharmaceuticals, after patents for the more expensive drugs lapse. The generic drug industry has created a major market, thanks to the lower pricing. According to the Center for Justice and Democracy at New York Law School, 80 percent of all drugs prescribed are generic, and generic drugs are chosen 94 percent of the time when they are available. But their manufacturers must be able to prove to the FDA that they can be effective substitutes for the original drugs. Some of the major generic drug makers include Zoetis, Inc., Allergan plc and Mylan N.V.

View a ticker or compare two or three
CRDL
Daily Signal:
Gain/Loss:
SNOA
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
CITR5.340.31
+6.16%
CitroTech Inc.
LBRT20.960.20
+0.96%
Liberty Energy
GPN88.29-0.01
-0.01%
Global Payments
SMWB8.07-0.03
-0.37%
Similarweb Ltd
NAMI1.83-0.09
-4.69%
Jinxin Technology Holding Company

SNOA and

Correlation & Price change

A.I.dvisor indicates that over the last year, SNOA has been loosely correlated with APUS. These tickers have moved in lockstep 41% of the time. This A.I.-generated data suggests there is some statistical probability that if SNOA jumps, then APUS could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To SNOA
1D Price
Change %
SNOA100%
-0.38%
APUS - SNOA
41%
Loosely correlated
-3.00%
CRDL - SNOA
28%
Poorly correlated
+0.76%
AKAN - SNOA
25%
Poorly correlated
+2.33%
CGC - SNOA
24%
Poorly correlated
-0.25%
RDHL - SNOA
23%
Poorly correlated
-1.48%
More